Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
4.940
-0.050 (-1.00%)
Jul 23, 2026, 11:56 AM EDT - Market open
IMDX Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, IMDX stock has a consensus rating of "Buy" and an average price target of $8.33. The average 1-year stock price forecast is 68.62% higher than the current stock price, while the lowest is $4.00 (-19.03%) and the highest is $12 (+142.91%).
Price Target: $8.33 (+68.62%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for IMDX stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Buy Maintains $12 | Buy | Maintains | $12 | +142.91% | Jul 23, 2026 |
| BTIG | BTIG | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 15, 2026 |
| Needham | Needham | Buy Maintains $9 | Buy | Maintains | $9 | +82.19% | May 14, 2026 |
Financial Forecast
Revenue This Year
2.15M
from 4.05M
Decreased by -47.05%
Revenue Next Year
7.72M
from 2.15M
Increased by 259.75%
EPS This Year
-0.85
EPS Next Year
-0.78
from -0.85
EPS and Forward PE are based on non-GAAP adjusted numbers.